These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37376631)

  • 1. Deoptimization of FMDV P1 Region Results in Robust Serotype-Independent Viral Attenuation.
    Medina GN; Spinard E; Azzinaro PA; Rodriguez-Calzada M; Gutkoska J; Kloc A; Rieder EA; Taillon BE; Mueller S; de Los Santos T; Segundo FD
    Viruses; 2023 Jun; 15(6):. PubMed ID: 37376631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synonymous Deoptimization of Foot-and-Mouth Disease Virus Causes Attenuation In Vivo while Inducing a Strong Neutralizing Antibody Response.
    Diaz-San Segundo F; Medina GN; Ramirez-Medina E; Velazquez-Salinas L; Koster M; Grubman MJ; de los Santos T
    J Virol; 2016 Feb; 90(3):1298-310. PubMed ID: 26581977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
    Zhou G; Wang H; Wang F; Yu L
    Res Vet Sci; 2013 Jun; 94(3):796-802. PubMed ID: 23267820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine.
    Wu Q; Moraes MP; Grubman MJ
    Virus Res; 2003 Jun; 93(2):211-9. PubMed ID: 12782369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.
    Moraes MP; Mayr GA; Mason PW; Grubman MJ
    Vaccine; 2002 Feb; 20(11-12):1631-9. PubMed ID: 11858872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T; Kenney M; Barrera J; Pandya M; Eckstrom K; Warner M; Pacheco JM; LaRocco M; Palarea-Albaladejo J; Brake D; Rieder E; Arzt J; Barlow JW; Golde WT
    Vaccine; 2019 Sep; 37(42):6221-6231. PubMed ID: 31493951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses.
    Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
    Steigerwald R; Brake DA; Barrera J; Schutta CJ; Kalla M; Wennier ST; Volkmann A; Hurtle W; Clark BA; Zurita M; Pisano M; Kamicker BJ; Puckette MC; Rasmussen MV; Neilan JG
    Vaccine; 2020 Jan; 38(4):769-778. PubMed ID: 31718901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Synonymous Deoptimization to Derive Modified Live Attenuated Strains of Foot and Mouth Disease Virus.
    Diaz-San Segundo F; Medina GN; Spinard E; Kloc A; Ramirez-Medina E; Azzinaro P; Mueller S; Rieder E; de Los Santos T
    Front Microbiol; 2020; 11():610286. PubMed ID: 33552021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs.
    Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Temperature-Dependent Translation Defect Caused by Internal Ribosome Entry Site Mutation Attenuates Foot-and-Mouth Disease Virus: Implications for Rational Vaccine Design.
    Yang D; Sun C; Gao R; Wang H; Liu W; Yu K; Zhou G; Zhao B; Yu L
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
    Schutta C; Barrera J; Pisano M; Zsak L; Grubman MJ; Mayr GA; Moraes MP; Kamicker BJ; Brake DA; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2016 Jun; 34(27):3214-3220. PubMed ID: 26707216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.
    Zheng H; Lian K; Yang F; Jin Y; Zhu Z; Guo J; Cao W; Liu H; He J; Zhang K; Li D; Liu X
    Vaccine; 2015 Oct; 33(43):5772-5778. PubMed ID: 26431990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability.
    Xie Y; Li H; Qi X; Ma Y; Yang B; Zhang S; Chang H; Yin X; Li Z
    Vaccine; 2019 Mar; 37(14):2016-2025. PubMed ID: 30808570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection and protection responses of deletion mutants of non-structural proteins of foot-and-mouth disease virus serotype Asia1 in guinea pigs.
    Lalzampuia H; Elango S; Biswal JK; Krishnaswamy N; Selvan RPT; Saravanan P; Mahadappa P; V Umapathi ; Reddy GR; Bhanuprakash V; Sanyal A; Dechamma HJ
    Appl Microbiol Biotechnol; 2022 Jan; 106(1):273-286. PubMed ID: 34889988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).
    Xu H; Bao X; Lu Y; Liu Y; Deng B; Wang Y; Xu Y; Hou J
    Vet Microbiol; 2017 Jun; 205():46-52. PubMed ID: 28622860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of two novel sublineages Ind2001BD1 and Ind2001BD2 of foot-and-mouth disease virus serotype O in Bangladesh.
    Siddique MA; Ali MR; Alam ASMRU; Ullah H; Rahman A; Chakrabarty RP; Amin MA; Hoque SA; Nandi SP; Sultana M; Hossain MA
    Transbound Emerg Dis; 2018 Aug; 65(4):1009-1023. PubMed ID: 29457368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle.
    Guo HC; Sun SQ; Jin Y; Yang SL; Wei YQ; Sun DH; Yin SH; Ma JW; Liu ZX; Guo JH; Luo JX; Yin H; Liu XT; Liu DX
    Vet Res; 2013 Jul; 44(1):48. PubMed ID: 23826638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
    Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
    Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.